Literature DB >> 20628261

Prehypertensive African-American women have preserved nitric oxide and renal function but high cardiovascular risk.

Deborah L Feairheller1, Kathleen M Sturgeon, Keith M Diaz, Praveen Veerabhadrappa, Sheara T Williamson, Deborah L Crabbe, Michael D Brown.   

Abstract

AIMS: African-Americans, in particular women, exhibit disproportionate levels of hypertension, inflammation, and oxidative stress compared to other ethnic groups. The relationship between prehypertension, renal function, inflammation, and oxidative stress was examined.
METHODS: Twenty-eight African-American women (53.5 +/- 1.1 years) followed an AHA diet and then underwent 24-hour ambulatory BP (ABP) monitoring. Urinary albumin (uAlb), serum and urinary creatinine, glomerular filtration rate (GFR), 24-hour urinary Na(+) excretion, plasma superoxide dismutase, total antioxidant capacity (TAC), urinary (uNOx) and plasma (pNOx) nitric oxide levels, and high-sensitivity C-reactive protein (hsCRP) were measured.
RESULTS: When the group was divided by average 24-hour ABP into optimal and nonoptimal groups, a significant difference existed between the groups for uNOx (p = 0.001; nonoptimal: 933.5 +/- 140.4, optimal: 425.0 +/- 52.6 mumol/gCr), and for hsCRP (p = 0.018, nonoptimal: 3.9 +/- 0.7, optimal: 1.9 +/- 0.6 mg/l). Significant inverse relationships existed between hsCRP and uNOx and between uAlb and pNOx in the non-optimal group, between GFR and pNOx in the entire group, and positive association existed between TAC and uNOx in the optimal group.
CONCLUSIONS: These results suggest that in African-American women as BP levels rise toward hypertension, the NO/NOS balance may be associated with renal function, and may have implications for CV risk based on their hsCRP levels. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20628261      PMCID: PMC3214938          DOI: 10.1159/000317944

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  50 in total

1.  Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects.

Authors:  P Clausen; J S Jensen; G Jensen; K Borch-Johnsen; B Feldt-Rasmussen
Journal:  Circulation       Date:  2001-04-10       Impact factor: 29.690

Review 2.  Nitric oxide in the control of renal hemodynamics and excretory function.

Authors:  D S Majid; L G Navar
Journal:  Am J Hypertens       Date:  2001-06       Impact factor: 2.689

3.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

Review 4.  Nitric oxide synthases: structure, function and inhibition.

Authors:  W K Alderton; C E Cooper; R G Knowles
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

5.  Is C-reactive protein an independent risk factor for essential hypertension?

Authors:  L E Bautista; P López-Jaramillo; L M Vera; J P Casas; A P Otero; A I Guaracao
Journal:  J Hypertens       Date:  2001-05       Impact factor: 4.844

6.  Total nitric oxide production is low in patients with chronic renal disease.

Authors:  R J Schmidt; C Baylis
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

7.  Increased basal nitric oxide release despite enhanced free radical production in hypertension.

Authors:  Angelo Maffei; Roberta Poulet; Carmine Vecchione; Salvatore Colella; Luigi Fratta; Giacomo Frati; Valentina Trimarco; Bruno Trimarco; Giuseppe Lembo
Journal:  J Hypertens       Date:  2002-06       Impact factor: 4.844

8.  Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells.

Authors:  Senthil Kumar Venugopal; Sridevi Devaraj; Ivan Yuhanna; Philip Shaul; Ishwarlal Jialal
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

9.  A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis.

Authors:  Subodh Verma; Chao-Hung Wang; Shu-Hong Li; Aaron S Dumont; Paul W M Fedak; Mitesh V Badiwala; Bikramjit Dhillon; Richard D Weisel; Ren-Ke Li; Donald A G Mickle; Duncan J Stewart
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

10.  Decreased nitric oxide synthesis in rats with chronic renal failure.

Authors:  S W Kim; J Lee; Y W Paek; D G Kang; K C Choi
Journal:  J Korean Med Sci       Date:  2000-08       Impact factor: 2.153

View more
  4 in total

1.  Racial differences in oxidative stress and inflammation: in vitro and in vivo.

Authors:  Deborah L Feairheller; Joon-Young Park; Kathleen M Sturgeon; Sheara T Williamson; Keith M Diaz; Praveen Veerabhadrappa; Michael D Brown
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

2.  Increased nitric oxide and attenuated diastolic blood pressure variability in african americans with mildly impaired renal function.

Authors:  Keith M Diaz; Deborah L Feairheller; Kathleen M Sturgeon; Praveen Veerabhadrappa; Sheara T Williamson; Deborah L Crabbe; Michael D Brown
Journal:  Int J Hypertens       Date:  2011-01-09       Impact factor: 2.420

3.  Racial differences in the responses to shear stress in human umbilical vein endothelial cells.

Authors:  Deborah L Feairheller; Joon-Young Park; Victor Rizzo; Boa Kim; Michael D Brown
Journal:  Vasc Health Risk Manag       Date:  2011-07-11

4.  Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production.

Authors:  Michael D Brown; Deborah L Feairheller; Sunny Thakkar; Praveen Veerabhadrappa; Joon-Young Park
Journal:  Vasc Health Risk Manag       Date:  2011-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.